Quick Links
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
April 25, 2019 -- Astellas and the U.S. Department of Justice (DOJ) have reached an agreement to resolve all claims raised by the government in its investigation regarding Astellas’ past donations to U.S. 501(c)(3) patient co-pay assistance foundations. The foundations are independent charitable organizations that provide financial assistance to patients who cannot afford the co-pay amounts for their medications.
Astellas denies any wrongdoing. These donations were conducted with the understanding that our actions were lawful and appropriate.
This settlement resolves the government’s investigation and includes a Corporate Integrity Agreement (CIA) with the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services for five years (through 2024).
We are pleased to resolve this matter and remain focused on pursuing our mission of turning innovative science into value for patients around the world.
Media Contact:
Colin McBean
colin.mcbean@astellas.com
847-420-3421
Follow U.S. news
